AS18587 Apex Utilities Inc.

Overview of AS18587

AS18587, known as Biogen Idec MA Inc., is an autonomous system (AS) owned by the biotechnology company Biogen. Biogen specializes in discovering, developing, and delivering therapies for people living with serious neurological and neurodegenerative diseases.

Owner of AS18587

The owner of AS18587 is Biogen Idec MA Inc., which is a branch of Biogen Inc. Biogen is an international biotechnology company based in the United States, with a focus on research and treatment for neurological diseases.

Main Operational Activity of AS18587's Owner

The main operational activity of AS18587's owner, Biogen, involves researching and developing innovative pharmaceuticals for conditions such as multiple sclerosis, Alzheimer's disease, and spinal muscular atrophy. The company's work includes drug discovery, clinical trials, and commercialization of therapies.

Establishment of AS18587

There is no readily available public information regarding the exact establishment date of AS18587. Autonomous systems are typically registered when needed by their respective organizations to manage their internet network infrastructure and online operations.

Malicious Use of AS18587

According to data from CleanTalk, a service that provides IP address blacklists for preventing spam, there does not appear to be significant evidence of hackers or spammers using AS18587 with malicious intent. The absence of substantial reports or listings on CleanTalk suggests that AS18587 maintains a clean reputation with respect to security and integrity.

It is important to note that while this information is accurate as of the last knowledge update, the status of any autonomous system, including AS18587, can change over time as new security threats emerge and are identified.